Overall, this study suggests that reducing the activation of the IRE1α-TRAF2-ASK1-JNK pathway by silencing RNF13 might be beneficial to alleviate some of the motor dysfunction and to prevent the dopaminergic neuron damage in a Parkinson’s disease mouse model [73]. Here, RNF13 is linked to Parkinson disease.